Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can attack many organs with varying degrees of severity. This can affect quality of life (QOL). SF36 is a commonly used QOL test. This study aims to report the validity and reliability test of the Indonesian Version of RAND SF-3...

Full description

Saved in:
Bibliographic Details
Main Authors: Anggraini Kartika Sari Prita, Amelia Kharina, Cahyani Frameiza
Format: Article
Language:English
Published: EDP Sciences 2024-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/pdf/2024/67/bioconf_icobeaf2024_01008.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526727353827328
author Anggraini Kartika Sari Prita
Amelia Kharina
Cahyani Frameiza
author_facet Anggraini Kartika Sari Prita
Amelia Kharina
Cahyani Frameiza
author_sort Anggraini Kartika Sari Prita
collection DOAJ
description Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can attack many organs with varying degrees of severity. This can affect quality of life (QOL). SF36 is a commonly used QOL test. This study aims to report the validity and reliability test of the Indonesian Version of RAND SF-36 in SLE patients. This research uses a cross sectional method and tested it on 19 eligible respondents. To test the reliability and validity of the questionnaire, analysis of the Cronbach coefficient and Pearson correlation was carried out. All subjects were women with an average age of 22.37 ± 5.10 years, the majority had secondary education (66.7%), were not married (79.2%), had no comorbidities (31.6%), and the duration of SLE was more than 3 years (62.5%). All of them used steroids as SLE therapy and also Mycophenolate mofetil (68.8%). The total value of Cronbach's alpha is 0.723 > 0.7, only two items were deemed appropriate RE scale (0.778) and GH scale (0.724). The validity sig value is < 0.005. In general, this study provides evidence that the Indonesian version of the RAND-SF 36 can be used to assess the QOL of SLE patients. However, there are limitations to the reliability of the scales. Further research or adjustments to the questions in the Indonesian version are required to enhance the reliability of the assessment.
format Article
id doaj-art-00f30031ebce4e9e862a05e4f4115f35
institution Kabale University
issn 2117-4458
language English
publishDate 2024-01-01
publisher EDP Sciences
record_format Article
series BIO Web of Conferences
spelling doaj-art-00f30031ebce4e9e862a05e4f4115f352025-01-16T11:19:45ZengEDP SciencesBIO Web of Conferences2117-44582024-01-011480100810.1051/bioconf/202414801008bioconf_icobeaf2024_01008Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliableAnggraini Kartika Sari Prita0Amelia Kharina1Cahyani Frameiza2Pharmacology and Clinical Pharmacy Department, Universitas Ahmad DahlanFaculty of Pharmacy, Universitas Ahmad Dahlan, YogyakartaFaculty of Pharmacy, Universitas Ahmad Dahlan, YogyakartaSystemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can attack many organs with varying degrees of severity. This can affect quality of life (QOL). SF36 is a commonly used QOL test. This study aims to report the validity and reliability test of the Indonesian Version of RAND SF-36 in SLE patients. This research uses a cross sectional method and tested it on 19 eligible respondents. To test the reliability and validity of the questionnaire, analysis of the Cronbach coefficient and Pearson correlation was carried out. All subjects were women with an average age of 22.37 ± 5.10 years, the majority had secondary education (66.7%), were not married (79.2%), had no comorbidities (31.6%), and the duration of SLE was more than 3 years (62.5%). All of them used steroids as SLE therapy and also Mycophenolate mofetil (68.8%). The total value of Cronbach's alpha is 0.723 > 0.7, only two items were deemed appropriate RE scale (0.778) and GH scale (0.724). The validity sig value is < 0.005. In general, this study provides evidence that the Indonesian version of the RAND-SF 36 can be used to assess the QOL of SLE patients. However, there are limitations to the reliability of the scales. Further research or adjustments to the questions in the Indonesian version are required to enhance the reliability of the assessment.https://www.bio-conferences.org/articles/bioconf/pdf/2024/67/bioconf_icobeaf2024_01008.pdf
spellingShingle Anggraini Kartika Sari Prita
Amelia Kharina
Cahyani Frameiza
Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable
BIO Web of Conferences
title Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable
title_full Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable
title_fullStr Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable
title_full_unstemmed Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable
title_short Outcome measurement in SLE patient: Indonesian version of RAND SF-36 summary scores and some scales were not reliable
title_sort outcome measurement in sle patient indonesian version of rand sf 36 summary scores and some scales were not reliable
url https://www.bio-conferences.org/articles/bioconf/pdf/2024/67/bioconf_icobeaf2024_01008.pdf
work_keys_str_mv AT anggrainikartikasariprita outcomemeasurementinslepatientindonesianversionofrandsf36summaryscoresandsomescaleswerenotreliable
AT ameliakharina outcomemeasurementinslepatientindonesianversionofrandsf36summaryscoresandsomescaleswerenotreliable
AT cahyaniframeiza outcomemeasurementinslepatientindonesianversionofrandsf36summaryscoresandsomescaleswerenotreliable